UTHR vs. MID

Last updated Apr 1, 2026

Compare and contrast key facts about United Therapeutics Corporation (UTHR) and American Century Mid Cap Growth Impact ETF (MID).

MID is an actively managed fund by American Century. It was launched on Jul 15, 2020.

Performance

UTHR vs. MID - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and American Century Mid Cap Growth Impact ETF (MID). The values are adjusted to include any dividend payments, if applicable.

UTHR vs. MID - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
UTHR United Therapeutics Corporation	21.70%	38.09%	60.46%	-20.93%	28.70%	42.35%	25.31%
MID American Century Mid Cap Growth Impact ETF	-6.21%	8.22%	19.40%	22.20%	-27.44%	10.39%	29.63%

Returns By Period

In the year-to-date period, UTHR achieves a 21.70% return, which is significantly higher than MID's -6.21% return.

UTHR

• 1D: 0.79%
• 1M: 17.68%
• YTD: 21.70%
• 6M: 41.45%
• 1Y: 92.36%
• 3Y*: 38.34%
• 5Y*: 25.25%
• 10Y*: 18.04%

MID

• 1D: 2.78%
• 1M: -6.95%
• YTD: -6.21%
• 6M: -7.93%
• 1Y: 8.02%
• 3Y*: 10.48%
• 5Y*: 3.90%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

UTHR vs. MID — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR

UTHR Risk / Return Rank: 93
UTHR Sharpe Ratio Rank: 89
UTHR Sortino Ratio Rank: 94
UTHR Omega Ratio Rank: 94
UTHR Calmar Ratio Rank: 95
UTHR Martin Ratio Rank: 94

MID

MID Risk / Return Rank: 24
MID Sharpe Ratio Rank: 22
MID Sortino Ratio Rank: 24
MID Omega Ratio Rank: 24
MID Calmar Ratio Rank: 25
MID Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. MID - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and American Century Mid Cap Growth Impact ETF (MID). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UTHR	MID	Difference
Sharpe ratio Return per unit of total volatility	1.84	0.35	+1.49
Sortino ratio Return per unit of downside risk	3.30	0.66	+2.64
Omega ratio Gain probability vs. loss probability	1.46	1.09	+0.37
Calmar ratio Return relative to maximum drawdown	5.70	0.53	+5.17
Martin ratio Return relative to average drawdown	14.49	1.73	+12.76
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UTHR vs. MID - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.84, which is higher than the MID Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of UTHR and MID, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	UTHR	MID	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.84	0.35	+1.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.72	0.17	+0.55
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.51	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.33	+0.07

Correlation

The correlation between UTHR and MID is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

UTHR vs. MID - Dividend Comparison

UTHR has not paid dividends to shareholders, while MID's dividend yield for the trailing twelve months is around 0.17%.

	TTM	2025	2024	2023
UTHR United Therapeutics Corporation	0.00%	0.00%	0.00%	0.00%
MID American Century Mid Cap Growth Impact ETF	0.17%	0.18%	0.17%	0.02%

Drawdowns

UTHR vs. MID - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, which is greater than MID's maximum drawdown of -40.15%. Use the drawdown chart below to compare losses from any high point for UTHR and MID.

Drawdown Indicators

	UTHR	MID	Difference
Max Drawdown Largest peak-to-trough decline	-93.18%	-40.15%	-53.03%
Max Drawdown (1Y) Largest decline over 1 year	-16.35%	-14.50%	-1.85%
Max Drawdown (5Y) Largest decline over 5 years	-33.00%	-40.15%	+7.15%
Max Drawdown (10Y) Largest decline over 10 years	-55.56%	—	—
Current Drawdown Current decline from peak	0.00%	-11.49%	+11.49%
Average Drawdown Average peak-to-trough decline	-35.53%	-13.68%	-21.85%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.43%	4.45%	+1.98%

Volatility

UTHR vs. MID - Volatility Comparison

United Therapeutics Corporation (UTHR) has a higher volatility of 17.05% compared to American Century Mid Cap Growth Impact ETF (MID) at 6.18%. This indicates that UTHR's price experiences larger fluctuations and is considered to be riskier than MID based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UTHR	MID	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.05%	6.18%	+10.87%
Volatility (6M) Calculated over the trailing 6-month period	26.84%	13.06%	+13.78%
Volatility (1Y) Calculated over the trailing 1-year period	50.41%	23.00%	+27.41%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.89%	23.71%	+12.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.32%	24.09%	+11.23%